Communiqués Allergan plc

Actions

AGN

IE00BY9D5467

Produits pharmaceutiques

Temps Différé NYSE			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		+1,73%	+0,97%

01/09	Allergan Aesthetics lance la crème apaisante Barrier Calming Cream et la brume faciale HA5 Hydra Collagen de SkinMedica	CI
07/04	Allergan Aesthetics inaugure un nouveau centre de formation AMI à Austin	CI

Communiqués

05/10/21	Hagens Berman: Law Firm Investigating Permanent Injuries and Disfigurement from Botched CoolSculpting Procedures	BU
16/04/21	Stamp Duty Battle: Abbvie Wins Appeal Against €587m Irish Stamp Duty	AQ
09/11/20	Allergan : an AbbVie company to Share New Data at American Academy of Ophthalmology 2020 Virtual	AQ
09/10/20	Allergan : an AbbVie Company, and Von Miller Encourage People with Glaucoma to Design Their Disease Management Plan	AQ
08/05/20	ALLERGAN PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
08/05/20	Allergan : AbbVie Inc. Completes Acquisition of Allergan plc	PR
07/05/20	Allergan : Foundation Doubles its COVID-19 Response Donations to $4.0 Million	PR
07/05/20	ALLERGAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
06/05/20	ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
06/05/20	Allergan : Announcement relating to the outcome of the Court Sanction Hearing	PR
05/05/20	AbbVie : and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie :'s Acquisition of Allergan	PR
05/05/20	Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC	AQ
28/04/20	Allergan : Announcement relating to the voluntary delisting of Allergan Notes	PR
27/04/20	Allergan : Form 8.3 -	AQ
27/04/20	Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLCl	AQ
23/04/20	Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC	AQ
21/04/20	ALLERGAN PLC : Temporary Suspension of Trading Under Registrant's Employee Benefit Plans, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
14/04/20	Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC	AQ
02/04/20	Allergan : China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucoma	PR
01/04/20	Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc	AQ
30/03/20	Allergan : Form 8.3 -	AQ
30/03/20	Allergan : Foundation Donates $2.0 Million to Community Organizations on Front-Line of COVID-19 Response	PR
24/03/20	Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC	AQ
18/03/20	Allergan : Declares Second Quarter 2020 Cash Dividend of $0.74 Per Ordinary Share	PR
18/03/20	ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ